• Iatrogenic lung disease (lecture)
To content Full text of article

Iatrogenic lung disease (lecture)

PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.1(73):133-139; doi 10.15574/PP.2018.73.133

Tsymbalista O. L., Vovk Z. V.
Ivano-Frankivsk National Medical University, Ukraine

The lecture presents the definition of the concept of iatrogenic lung disease, the analysis of risk factors for its development, the response of pulmonary tissue and the effect of toxic substances. The response is stereotyped and consists primarily in the development of parenchymal respiratory failure. All structures of the bronchopulmonary system serve as the targets for drug toxicity. The characteristics of iatrogenic lung injury depending on treatment with certain drugs is presented. The most common clinical forms of iatrogenic lung disease (drug!induced eosinophilic lung disease, interstitial pneumonitis, drug!induced vasculitis, bronchial asthma, obliterating bronchitis, pulmonary edema, lupus!like syndrome) are characterized.
Key words: iatrogenic lung disease, clinic, diagnosis, therapy.
References

1. Baranov AA, Volodin NN, Samsygina GA et al. (2007). Rational pharmacotherapy for childhood diseases: a guide for practicing physicians in 2 volumes. Baranov AA, Volodin NN, Samsygina GA, editors. Moscow. Littera. 1: 1163.

 2. Belousov YuB. (2010). Clinical pharmacology and pharmacotherapy. Moscow.  Meditsinskoye informatsionnoye agentstvo: 872.

3. Berezhnyi VV. (2016). Drug-induced disease in children: clinical lecture. Sovremennaya pediatriya, 4: 14-17.

4. Respiratory diseases. Paleev NR, editor. (2000). Moscow. Meditsina: 728.

5. Borisova AM, Borisova NK, Gembitskaya TYe et al. (1990). Respiratory diseases: a guide for physicians in 4 volumes. Paleev NR, editor. Moscow. Meditsina. 4: 624.

6. Vatutin NT, Toradin GG, Gritsenko YuP. (2016). Lung injury as a complication of treatment with amiodarone. Russian Pulmonology. 26(2): 246-253.

7. Pediatric hematology and immunology: a guide for physicians. Alekseyeva NA, editor. (2009). Saint Petersburg. Gippokrat. 1027p.

8. Babak OYa, Bilovol OM, Chekman IS. (2010). Clinical pharmacology. Babak OYa, Bilovol OM, Chekman IS, editors. Kyiv. Medytsyna. 774.

9. Knyazkova II. (2016). The question of drug therapy safety in pediatrics. Zdorovia Ukraiiny. 4: 56-58.

10. Koval HYu, Syvachenko TP, Zahorodska MM et al. (1998). X-ray diagnostics: in 2 volumes. Koval HYu, editor. Kyiv. Orbis.1: 177-179.

11. Kogan YeA, Kornev BM, Popova YeN et al. (2007). Interstitial lung disease: a practical guide. Mukhin NA, editor. Moscow. Littera. 432р.

12. Mozhdrakov G, Popkhristov P. (1973). Drug-induced disease. Mozhdrakov G, Popkhristov P, editors. Sofia. Meditsina i fizkultura: 605.

13. Parshin VD, Bogomolova NS, Vishnevskaya et al. (2010). Antimicrobial and antimycotic therapy in surgery of iatrogenic esophageal and tracheal diseases. Khirurgiya. Zhurnal imeni N.I. Pirogova. 1: 4-10.

14. Parshin VD, Bogomolova NS, Vishnevskaya GA et al. (2010). Infectious complications in patients with iatrogenic diseases of the trachea and esophagus. Anesteziologiia i Reanimatologiia. 5: 69-72.

15. Postnikov SS, Gratsianskaya AN, Kostyleva MN. (2013). Drug-induced lung disease. Journal “Pediatria” named after G.N. Speransky. 92(3): 130-135.

16. Postnikov SS, Kostyleva MN, Gratsianskaya AN. (2011). Drug-induced fever. Journal “Pediatria” named after G.N. Speransky. 90(6): 125-129.

17. Chuchalin AG. (2009). Pulmonology: a national guideline. Chuchalin AG, editor. Moscow. GEOTAR-Media: 960.

18. Rozinova NN, Mizernitskiy YuL. (2011). Chronic lung diseases in children. Rozinova NN, Mizernitskiy YuL, editors. Moscow. Praktika. 224.

19. Feshchenko YuI, Rekalova YeM, Begouleva ZhB et al. (2004). Two cases of amiodarone-induced pulmonary toxicity. Ukrainian Pulmonology Journal. 4: 55-58.